1. Home
  2. XELB vs NLSP Comparison

XELB vs NLSP Comparison

Compare XELB & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XELB
  • NLSP
  • Stock Information
  • Founded
  • XELB 2011
  • NLSP 2015
  • Country
  • XELB United States
  • NLSP Switzerland
  • Employees
  • XELB N/A
  • NLSP N/A
  • Industry
  • XELB Multi-Sector Companies
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • XELB Miscellaneous
  • NLSP Health Care
  • Exchange
  • XELB Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • XELB 10.6M
  • NLSP 12.4M
  • IPO Year
  • XELB N/A
  • NLSP 2021
  • Fundamental
  • Price
  • XELB $1.29
  • NLSP $1.05
  • Analyst Decision
  • XELB Strong Buy
  • NLSP
  • Analyst Count
  • XELB 1
  • NLSP 0
  • Target Price
  • XELB $3.00
  • NLSP N/A
  • AVG Volume (30 Days)
  • XELB 2.4M
  • NLSP 1.0M
  • Earning Date
  • XELB 08-14-2025
  • NLSP 10-06-2025
  • Dividend Yield
  • XELB N/A
  • NLSP N/A
  • EPS Growth
  • XELB N/A
  • NLSP N/A
  • EPS
  • XELB N/A
  • NLSP N/A
  • Revenue
  • XELB $5,774,000.00
  • NLSP N/A
  • Revenue This Year
  • XELB N/A
  • NLSP N/A
  • Revenue Next Year
  • XELB $76.74
  • NLSP N/A
  • P/E Ratio
  • XELB N/A
  • NLSP N/A
  • Revenue Growth
  • XELB N/A
  • NLSP N/A
  • 52 Week Low
  • XELB $0.95
  • NLSP $1.03
  • 52 Week High
  • XELB $8.49
  • NLSP $4.74
  • Technical
  • Relative Strength Index (RSI)
  • XELB 34.09
  • NLSP 22.47
  • Support Level
  • XELB $1.96
  • NLSP $1.60
  • Resistance Level
  • XELB $2.27
  • NLSP $1.36
  • Average True Range (ATR)
  • XELB 0.15
  • NLSP 0.13
  • MACD
  • XELB -0.10
  • NLSP -0.06
  • Stochastic Oscillator
  • XELB 1.01
  • NLSP 2.89

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: